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Abstract: We formulate a mathematical model to explore the transmission dynamics of human 
papillomavirus (HPV). In our model, infected individuals can recover with a limited immunity that 
results in a lower probability of being infected again. In practice, it is necessary to revaccinate 
individuals within a period after the first vaccination to ensure immunity to HPV infection. 
Accordingly, we include vaccination and revaccination in our model. The model exhibits backward 
bifurcation as a result of imperfect protection after recovery and because the basic reproduction 
number is less than one. We conduct sensitivity analysis to identify the factors that markedly affect 
HPV infection rates and propose an optimal control problem that minimizes vaccination and 
screening cost. The optimal controls are characterized according to Pontryagin’s maximum principle 
and numerically solved by the symplectic pseudospectral method. 
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1. Introduction 
Uterine cervical cancer is a worldwide health problem but it is especially concerning in 
developing countries. It is the first or second most common cancer in women [1]. It is estimated that 
the probability of a person being infected with human papillomavirus (HPV) in their lifetime 
reaches 70 to 80% [2], and the total infection rate in the global population is as high as 11.7% [3]. 
An estimated 233,000 deaths were attributed to HPV infection in the year 2000 [4]. There were 
approximately 500,000 cases and 275,000 deaths due to cervical cancer worldwide in 2002, 
equivalent to about a tenth of all deaths in women due to cancer [5]. The burden of cervical cancer is 
disproportionately high (> 80%) in the developing world [6]. 
HPV was discovered to be the causative agent of cervical cancer in the 1970s by the Zur Hausen 
group [7]. Usually, the infecting papillomavirus is eliminated from individuals; however, some 
individuals retain the virus. Persistent infection with oncogenic HPV is recognized as the major 
cause of uterine cervical cancer [8]. Cervical carcinogenesis is a complex stepwise process over a 
continuum of increasingly severe precancerous changes known collectively as cervical intraepithelial 
neoplasia (CIN) [9]. The spectrum of CIN is traditionally divided into three histopathological categories: 
CIN1, CIN2 and CIN3. In CIN1, cells with malignant changes are limited to the superficial layer of the 
cervical epithelium. Most CIN1 lesions are likely to disappear without treatment. However, a small 
percentage may progress to high-grade CINs (i.e., CIN2 and CIN3). The risk of progression to invasive 
cervical cancer increases significantly with worsening CIN grades [10–11]. 
Pap cytology screening for the early detection of cervical neoplasia has been successful in 
reducing cervical cancer incidence and mortality [12]. In unscreened populations, the risk of invasive 
cervical cancer occurs earlier than of most adult cancers, peaking or reaching a plateau between 
about 35 and 55 years of age [13]. This distribution is because cervical cancers originate mainly from 
HPV infections transmitted sexually in late adolescence and early adulthood [14]. HPV transmission 
can be reduced through the use of condoms [15]. Some studies have reported that smoking [16], 
multiparity [17], and long-term use of oral contraceptives [18] can double or triple the risk of 
precancer and cancer among women infected with carcinogenic types of HPV. There are two major 
kinds of anti-HPV vaccines approved for use to protect newly sexually active individuals against 
some of the most common HPV types and boost immunity, namely, therapeutic vaccines and 
prophylactic vaccines [7]. A few years after receiving a prophylactic vaccine, the individual must be 
revaccinated because the vaccine loses its preventive effect. Progress in the development of 
therapeutic vaccines for HPV has been slow [7]. In summary, there is currently no specific treatment 
for HPV infection [19]. There are three major treatments for cervical cancer: surgery (such as total 
hysterectomy and subtotal hysterectomy), radiotherapy, and chemotherapy. Among these, surgery 
and radiotherapy are the main treatment methods [19]. 
Mathematical modeling is a useful tool for assessing the potential impact of intervention 
strategies against HPV spread among humans [20−24]. A number of authors have reported the use of 
mathematical modeling to evaluate the impact of HPV vaccination. Al-arydah [20] developed a 
two-sex, age-structured model to describe a vaccination program for the administration of an HPV 
vaccine. Malik et al. [11] presented an age-structured mathematical model that incorporated sex 
structure and Pap screening cytology. Sharomi and Malik [21] developed a two-sex HPV vaccination 
model to study the effect of vaccine compliance on HPV infection and cervical cancer. Omame [22] 
developed a two-sex deterministic model for HPV that assessed the impact of treatment and 
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vaccination. Elbasha [23] presented a two-sex, deterministic model for assessing the potential impact 
of a prophylactic HPV vaccine with several properties. 
Based on the above research and understanding of HPV pathology, we develop an ordinary 
differential equation model with precautionary measures such as screening, which are rarely 
considered in previous studies, and analyze the potential effects of multiple factors on HPV 
transmission. The model is formulated in section 2. In section 3, the equilibria, basic reproduction 
number, and global stability are analyzed. We report the sensitivity analysis of the model through the 
partial rank correlation coefficient (PRCC) method and identify the key factors in the model in 
section 4. In section 5, we set the vaccination rate and screening rate as control variables and analyze 
an optimal control problem that minimizes vaccination and screening cost. Section 6 concludes the 
article. Through extensive numerical simulations with MATLAB, we obtained results to verify our 
conclusions. 
2. An HPV model with vaccination and screening 
The total individual population at time t is divided into 10 mutually exclusive subpopulations of 
susceptible individuals S(t), vaccinated individuals V(t), infectious individuals without disease 
symptoms E(t), infectious individuals with disease symptoms H(t), individuals with persistent HPV 
infection P(t), CIN1 symptomatic individuals I1(t), CIN2 symptomatic individuals I2(t), CIN3 
symptomatic individuals I3(t), cancer-infected individuals A(t) and recovered individuals R(t). As 
such, the total population is 
                     1 2 3N t V t S t E t H t P t I t I t I t A t R t          . 
Susceptible individuals acquire HPV infection, following effective contact with infected 
individuals (i.e., those in the E , H , P , 1I , 2I  and 3I  classes) at the rate 1  as follows 
 
  1 2 3 1 4 2 5 3
1
1n k c ac c c c E H P I I I
t
N
     

     
 .        (1) 
It follows that the model for the transmission of HPV is given by the following system of 
differential equations. 
 
Figure 1. Flow diagram of model (2). 
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(2a)        2 4 1
dV
S t S t d V t
dt
      , 
(2b)       1 2 4 1
dS
V t t d S t
dt
          , 
(2c)              1 3 1 2 2 1 1p q
dE
t S t t R t H t c c d E t
dt
            ,  
(2d)        2 3 2 2 2 3
dH
E t P t d H t
dt
           , 
(2e)        3 4 1 4 3 3 3
dP
H t I t d P t
dt
           ,          (2) 
(2f)        1 4 5 2 5 4 4 4 1
dI
P t I t d I t
dt
           , 
(2g)        2 5 1 6 3 5 5 5 6 2
dI
I t I t d I t
dt
           , 
(2h)      3 6 2 6 6 6 7 3
dI
I t d I t
dt
         , 
(2i)      7 3 7 1
dA
I t d d A t
dt
     , 
(2j) 
             
    
1 1 2 2 3 3 4 4 1 5 5 2 6 6 3 7
3 1        .
p q
dR
c c E t H t P t I t I t I t A t
dt
t d R t
            
 
      
 
 
Table 1. Description of variables in model (2). 
Variable Description 
 V t  Vaccinated individuals 
 S t  Susceptible individuals 
 E t  Infectious individuals with no symptoms 
 H t  Infectious individuals with symptoms 
 P t  Infectious individuals with persistent infection 
 1I t  Cervical intraepithelial neoplasia grade 1 (CIN1) 
 2I t  Cervical intraepithelial neoplasia grade 2 (CIN2) 
 3I t  Cervical intraepithelial neoplasia grade 3 (CIN3) 
 A t  Cancer-infected individuals 
 R t  Recovered individuals 
Tables 1 and 2 list the associated state variables and parameters of model (2). Figure 1 shows 
the flow diagram of the model. We emphasize that the vaccine mentioned in model (2) is a 
prophylactic vaccine. In the following section, model (2) is qualitatively analyzed to derive insights 
into its dynamical features. 
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Table 2. Description of the parameters in model (2). 
Parameter Description 
  Recruitment rate into the susceptible population (per year) 
d  Natural death rate (per year) 
1d  Disease-induced mortality for individuals (per year) 
1  Effective contact rate 
1  Vaccine failure rate (per year) 
2 , 4  Vaccination rate and revaccination rate (per year) 
3  
The modification parameter for the probability of R being infected 
relative to S  
pc  The effect of screening by HPV testing 
qc  Screening frequency (per year) 
nc  Rate at which females (males) acquire new sexual partners (per year) 
kc  
The probability of transmitting HPV from female (male) to male 
(female) 
cc  Condom efficacy 
ac  Condom compliance (per year) 
  The negative effects of contraceptive drugs 
  The negative effects of smoking 
2 , 3 , 4 , 5 , 6 , 7  
Progression rate of infectious individuals from E  to H , H  to P , 
P  to 1I , 1I  to 2I , 2I  to 3I , 3I  to A  (per year) 
1 , 2 , 3 , 4 , 5 , 6  
Recovery rates of infectious individuals from E  to R , H  to E , 
P  to H , 1I  to P , 2I  to 1I , 3I  to 2I  (per year) 
1 , 2 , 3 , 4 , 5 , 6 ,
7  
Effect of drugs on infectious individuals’ recovery 
1 , 2 , 3 , 4 , 5  
Modification parameter that accounts for the infectiousness of 
individuals in the H , P , 1I , 2I , 3I  classes relative to those in the 
E  class for females (males) 
3. Analysis of the model 
3.1. Basic properties 
3.1.1. Positivity and boundedness of solutions 
Model (2) is epidemiologically and mathematically well-posed in the epidemiologically valid 
domain 
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 

10
1 2 3
1 2 3
, , , , , , , , ,
                          0, 0, 0, 0, 0, 0, 0, 0, 0, 0 .
D V S E H P I I I A R R
V S E H P I I I A R
 
         
 
Theorem 3.1 Assuming that the initial condition lies in domain D , then the solutions 
 1 2 3, , , , , , , , ,V S E H P I I I A R  of model (2) remain in D for all time 0t  . Furthermore 
 limsup
t
N t
d

 , with 1 2 3N V S E H P I I I A R          . 
Proof. We note that along the edges of D, the time derivatives all lead the solution into the invariant 
domain [25] 
0 0V V     (2a), 
0 0S S     (2b), 
0 0E E    (2c), 
0 0H H     (2d), 
0 0P P    (2e), 
1 10 0I I
    (2f), 
2 20 0I I
    (2g), 
3 30 0I I
    (2h), 
0 0A A    (2i), 
0 0R R    (2j). 
Furthermore, adding all the equations in the differential equation system of model (2) gives 
1 2 3 1
dN
dV dS dE dH dP dI dI dI dA dR d A
dt
             .   (3) 
It follows from Eq (3) that 
 1
dN
d d N dN
dt
       . 
Therefore 
   
1
liminf limsup
t t
N t N t
d d d 
 
  

, 
and 
 limsup
t
N t
d

 , 
as required. 
3.1.2. Invariant regions 
Model (2) is analyzed in a biologically-feasible region as follows [26]. We first show that model (2) 
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is dissipative (i.e., all feasible solutions are uniformly bounded in a proper subset 10R ). 
Consider the region 
  101 2 3
1 2 3
, , , , , , , , , :
                          .
V S E H P I I I A R R
V S E H P I I I A R
d
  

          

 
The following steps establish the positive invariance of   (i.e., solutions in   remain in   
0t  ). It follows from Eq (3) that 
dN
dN
dt
   . 
A standard comparison theorem can then be used to show that 
     0 1dt dtN t N e e
d
    . 
In particular 
 N t
d

  if  0N
d

 . 
Thus, the region   is positively invariant. Hence, it is sufficient to consider the dynamics of 
the flow generated by model (2) in  . In this region, the model can be considered as being 
epidemiologically and mathematically well-posed [27]. Thus, every solution of model (2) with initial 
conditions in   remains in   for all 0t  . Therefore, the  -limit sets of model (2) are 
contained in  . This result is summarized below. 
Lemma 3.1 The region   is positively invariant for model (2) with initial conditions in 10R . 
3.2. Local stability of the disease-free equilibrium (DFE) 
Model (2) has a DFE, which is obtained by setting the right-hand sides of the equations in the 
model to zero, given by 
 
 
   
0 0 0 0 0 0 0 0 0 0
0 1 2 3
2 4 1
1 2 1 2 4 1 2 1 2 4
, , , , , , , , ,
      , ,0,0,0,0,0,0,0,0
V S E H P I I I A R
a
a a a a

 
     

   
       
.         (4) 
Let  1 2 3, , , , , , , , ,
T
V S E H P I I I A R  . Using the notation from [28], the model consists of 
nonnegative initial conditions together with the following system of equations: 
   
dX
X X
dt
   , 
where 
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   
 
 
 
 
 
 
3 1 2 2 1 1
1
2 3 2 2 2 3
3 4 1 4 3 3 3
4 5 2 5 4 4 4 1
5 1 6 3 5 5 5 6 2
6 2 6 6 6 7 3
7 3 7
0
0
0
0
,  
0
0
0
0
0
p qR H c c d E
S
E P d H
H I d P
P I d I
I I d I
X X I d I
I
     

     
     
     
     
    
 
    
 
      
       
 
      
       
 
         
 
   
 
 
 
 
 
 
 
 
 
 
1
1 2 4 1
1 1 2 2 3 3 4 4 1 5 5 2 6 6 3 7
3 1
2 4 1
,
        
p q
d d A
V d S
c c E H P I I I A
d R
S S d V
   
            
 
  
 
 
 
 
 
 
 
 
 
 
 
      
 
       
 
  
     
 
and it follows that 
 
0
0 0
F
D X
 
   
 
,  
3 4
0V
D X
J J
 
   
 
. 
The matrices F  and V  for the new infection terms and the remaining transfer terms are 
respectively given by 
1 2 5 4 3
10
1
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
F a
     
 
 
 
  
 
 
 
 
, 
3 2
2 4 3
3 5 4
8 6
6 7 5
4 5 6
0 0 0 0
0 0 0
0 0 0
0 0 0 0
0 0 0
0 0 0
a
a
a
V
a
a
a

 
 

 
 

 
  
 
  
  
 
  
 
   
, 
7
1 1 2 2 3 3 6 6 5 5 4 4
3
10 10 1 10 2 10 5 10 4 10 3
0 0 0 0 0
0 0 0 0 0 0
p qc c
J
a a a a a a

           
    
 
      
 
 
 
 
, 
9
7
4
2 1
2 4 1
0 0 0
0 0
0 0
0 0
a
d
J
a
a


 
 
 
 
 
 
  
, 
where 
1 1a d   , 2 2 4a d    , 3 2 1 1p qa c c d     , 
4 2 2 2 3a d       , 5 4 3 3 3a d       , 6 5 4 4 4a d       , 
7 5 5 5 6a d       , 8 6 6 6 7a d       , 9 7 1a d d   , 
1
10
1 2 3
Ma
a
a  

 
,  1n k c aM c c c c  . 
We obtain 
 
  
1 1 1
0
3 6 2 5 1 2 4
a MM
R FV
a D D a

  

 
  
,               (5) 
where 
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1 6 1 5 2 4 3 3 4 2 5M D D D D D         , 
7
1
9
D
a

 , 82
6
a
D

 , 
7 2 6
3
5
0
a D
D



  , 6 3 5 24
4
0
a D D
D



  , 5 4 4 35
3
0
a D D
D



  , 
4 5 3 4
6
2
0
a D D
D



  . 
Consequently, it follows from Theorem 2 of [28]. 
Lemma 3.2 The DFE of model (2), given by (4), is locally asymptotically stable (LAS) when R0 < 1 
and unstable if R0 > 1. 
3.3. Backward bifurcation 
The epidemiological significance of forward bifurcation is that the disease will eventually 
disappear if the basic reproduction number is less than one. The public health significance of 
backward bifurcation is that the classical requirement of R0 < 1 although necessary is no longer 
sufficient for effective disease control. Therefore, the presence of backward bifurcation in HPV 
transmission dynamics makes its effective control more difficult. 
3.3.1. Existence of backward bifurcation 
First, the possible equilibrium solutions that model (2) can have are determined as follows. Let 
 1 * * * * * 1* 2* 3* * *, , , , , , , , ,V S E H P I I I A R  , 
be any arbitrary equilibrium of model (2). Further, let 
  * 1 * 2 * 3 1* 4 2* 5 3*
1*
*
1n k c ac c c c E H P I I I
N
     

     
 ,      (6) 
be the associated force of infection at a steady state. 
Setting the right-hand sides of model (2) to zero (steady state) gives 
* 1 3*A D I , 2* 2 3*I D I , 1* 3 3*I D I , * 4 3*P D I , * 5 3*H D I , * 6 3*E D I , 
7
* 3*
3 1*
D
R I
d  


, 3 6 3 7 2 5* 3*
1* 3 1* 1*
a D D D
S I
d
 
   
 
   
 
,                              (7) 
3 6 3 7 2 52 4
* 3*
1 1* 3 1* 1*
a D D D
V I
a d
  
   
 
   
 
, 
where 
7 1 1 6 2 2 5 3 3 4 4 4 3 5 5 2 6 6 7 1p qD c c D D D D D D                   . 
Substituting (7) into the expressions for 1*  in (6) gives 
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 6 1 5 2 4 3 4 2 5 3*
1*
3 6 3 7 2 5 72 4
3* 8 3* 3*
1* 3 1* 1* 1 3 1
3
*
1
M D D D D D I
a D D D D
I D I I
d a d
   

   
 

   
   

  
      
  


,     (8) 
so 
2
1* 1* 0a b c    ,                             (9) 
where 
8 3 1a D a , 
     3 0 3 6 2 5 1 2 4 7 1 8 1 7 3 1 2 41b R a D D a D a D a d D a                , 
   0 3 6 2 5 1 2 41c d R a D D a       , 
and 
8 6 5 4 3 2 1+ 1D D D D D D D      . 
Quadratic Eq (9) can be analyzed for the possibility of multiple endemic equilibria. It is worth 
noting that the coefficient a  is always positive, and c  is positive (negative) if 0R  is less than 
(greater than) one. Hence, the following result is established. 
Theorem 3.2 Model (2) (details in Appendix A (Table A1)) has the following. 
i. A unique endemic equilibrium if 
00 1c R   ; 
ii. A unique endemic equilibrium if 0b  , and 0c   or 2 4 0b ac  ; 
iii. Two endemic equilibria if 0c  , 0b   and 2 4 0b ac  ; 
iv. No endemic equilibrium otherwise. 
Case (iii) of Theorem 3.2 indicates the possibility of backward bifurcation in model (2) when
0 1R  . To check for this, by setting 
  
2
1
3 6 2 5 1 2 4
1
b
R
d a D D a  
 
  
, 
it can be shown that backward bifurcation occurs for values of 1 0 1R R  . This phenomenon is 
illustrated by simulating model (2). The parameter values are presented in Table 3. Let 
 0.35,0.5M  . It should be mentioned that the aforementioned parameter values may not all be 
epidemiologically realistic. 
 
Figure 2. Backward bifurcation diagram of model (2). 
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Table 3. Parameter values used in Figure 2 ( A: Assumed). 
Parameter Value Source Parameter Value Source Parameter Value Source 
  288802  [22] 3  0.005  [11] 1  1.5  A 
d  0.0162  [22] 4  0.1  [11] 2  1.5  A 
1d  0.01  [11] 5  0.02  [11] 3  1.2  A 
1  0.1  [11] 6  0.04  [11] 4  1.1 A 
2  0.87  [22] 7  0.08  [11] 5  1.05  A 
3  0.3  [22] 1  0.99  [11] 6  1.03  A 
4  0.27  A 2  9 4e  [22] 7  1.01 A 
pc  0.9  A 3  0.5  [22] 4  0.6  A 
qc  0.4  A 4  1.9 7e  A 5  0.5  A 
5  1.9 7e  A 1  1 A 2  0.8  [22] 
2  0.5  [22] 6  1.9 7e  A 3  0.7  A 
The associated backward bifurcation diagram, depicted in Figure 2, shows that the model has a 
DFE (corresponding to Figure 3) and two endemic equilibria: One of the endemic equilibria is LAS 
(corresponding to Figure 4a); the other is unstable (a saddle); and the disease-free equilibrium is LAS. 
This clearly shows the coexistence of two stable equilibria when 0 1R  , confirming that the model 
exhibits backward bifurcation for 1 0 1R R  . This result is summarized below for model (2) (a 
more rigorous proof of the backward bifurcation phenomenon of the model, using the center 
manifold theory is given in Appendix B). 
 
Figure 3. Variation in population with 0 0.6659R   and 1 0.9976R  . 
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Figure 4. Variation in population with (a) 0 0.9988R  , 1 0.8144R  ; (b) 0 2.2196R  . 
Theorem 3.3 Model (2) exhibits backward bifurcation when Case (iii) of Theorem 3.2 holds and 
1 0 1R R  . 
3.3.2. Effect of perfect protection after recovery on backward bifurcation 
Consider model (2) with perfect protection after recovery (that is, 3 0  ). In such a case, the 
basic reproduction number is 
30 0 0
R R  
  . It follows from Eq (9) that if 3 0  , the coefficients 
0a   and 0b  , so quadratic Eq (9) reduces to a linear equation in 1*  (with 1* /c b   ). In 
this case, model (2) has a unique endemic equilibrium if 0c   (i.e., 0 1R
  ), ruling out backward 
bifurcation in the model for this case (the presence of two endemic equilibria when 0 1R
   is 
necessary for the existence of backward bifurcation). Furthermore, it follows that 0c   when 
0 1R
  . Thus, in such a case (with 0a c  ), quadratic Eq (9) has only the trivial solution 1* 0   
(which corresponds to the DFE 0 ). This result is summarized below. 
Lemma 3.3 Consider the case where the protection after recovery is perfect ( 3 0  ). Model (2) has 
a unique endemic equilibrium whenever 0 1R
   and no endemic equilibrium otherwise. 
3.4. Global stability of the DFE 
Theorem 3.4 In the first quadrant, there is no limit cycle in model (2). 
Proof We consider the Dulac function as  
1
,B S E
SE
 . Let 
1 2 3 1 4 2 5 3Q E H P I I I          . 
Hence Q E  and N R . Therefore, 
2
0
MQ MQR
N N
  , 
2 2
0
EM MQ
E N E N
  . 
Then, 
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                   1 2 3
1 2 3
31 1 2
2 2 2 2 2 2 2 2 2
5 5 6 7 8 9 34
   
 
BV BS BE BH BP BI BI BI BA BR
V S E H P I I I A R
Ra V HMQ EM MQ MQ EM MQ MQ
SE S E EN E N EN E N S E N EN E N SE
a a a a a aa d MQ M
SE SE SE SE SE SE SE SE SE N
 

         
          
         
     
             
   
         
2
0.
QR
N
 
 
 
  
Therefore, by the Dulac−Bendixson theorem [29], there is no periodic orbit for model (2). Moreover, 
0  is the unique positive equilibrium point in 
10R  if 3 0  , and it is also locally asymptotically 
stable for 0 1R  . Hence, every positive solution actually approaches 0 . Thus, 0  is globally 
asymptotically stable if 3 0   and 0 1R  . 
4. Efficacy of interventions and sensitivity analysis 
In this section, we performed a numerical simulation to enhance the understanding of model (2). 
4.1. Efficacy of interventions 
To examine the possible impact of interventions on disease infections we plot the number of 
infected individuals ( E ) with various vaccination rates and revaccination rates. 
 
Figure 5. Variation in population E  with different parameters (a) 2 ; (b) 2 4  . 
This analysis shows that an increasing vaccination rate persistently decreases the peak value, 
as shown in Figure 5. Increasing the vaccination rate 
2  by 1.75 times (increase from 0.4 to 0.7) 
or 1.43 times (increased from 0.7 to 1) will lead to a reduction in the peak value in the number of 
E  by 20.21% or by 15.67%, respectively. In addition, the peak value of the number of people 
infected with 
2 1   decreased by 43.82% compared with the number of people infected with 
2 0  . 
On the premise that the vaccine’s protective effect will end after a few years, we consider the 
situation of vaccination and revaccination. Figure 5b indicates that increasing 2  and 4  from 0 to 0.4 
will lead to a reduction in the peak value in the number of E  by 34.16%. In addition, the peak 
value of the number of people infected with 2 4 0.7    decreased by 100% compared with the 
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number of people infected with 2 4 0   . 
4.2. Sensitivity analysis of 0R  to parameters 
To identify the factors associated with a certain intervention that markedly affect the rate of new 
infections, we performed sensitivity analysis of the basic reproduction number. 
LHS belongs to the MC class of sampling methods; it was introduced by Mckay et al. [30]. LHS 
allows an unbiased estimate of the average model output and has the advantage that it requires fewer 
samples than simple random sampling to achieve the same accuracy. For nonlinear but monotonic 
relationships between outputs and inputs, measures that work well are based on rank transforms such 
as the partial rank correlation coefficient, and standardized rank regression coefficient. 
Model (2) has 39 parameters. To identify the key factors, following [30], we performed a Latin 
hypercube sampling on the parameters that appear in 0R  and calculated the PRCC. The parameters 
of the model were set as input variables, and 0R  was the output variable. Generally, in PRCC 
analysis, the parameters with large PRCC values and corresponding small p  values are deemed to 
be the most influential parameters in the model. 
 
Figure 6. Significance test of model parameters and PRCC results for 0R . 
Detailed inspection of Table C1 (Appendix C) and Figure 6 indicates that in terms of reducing 
the value of 0R , except 3  (control the disease and reduce the number of persistent infections) and 
d , the vaccination rate 2  is the most sensitive parameter with a leading PRCC value, followed by 
2 , 3 , 2 , 4 . This implies that enhancing the vaccination rate is the most effective intervention 
for lowering HPV new infections. Moreover, in the treatment of patients in stages H , P , 1I , 2I  
and 3I , the effect of treatments 2 , 3 , 4 , 5  and 6  on 0R  decreases successively. That is, 
the same treatment intervention is more effective in the earlier stages. This means that more attention 
should be paid to patients in the early stages of infection. As asymptomatic patients are unable to 
diagnose themselves, regular screening for HPV should be strengthened. Smoking, overuse of 
contraceptive drugs, and unsafe sexual life will increase the value of 
0R , thus promoting the spread 
of HPV. 
5463 
Mathematical Biosciences and Engineering  Volume 17, Issue 5, 5449−5476. 
5. Optimal control in an extended model 
In this section, an optimal control model for the transmission dynamics of HPV is formulated by 
extending model (2) to include control functions. Our goal here is to study the optimal control 
strategies to curtail the epidemic and minimize cost. 
5.1. An extended HPV model 
The optimal vaccination and screening strategy can be formulated as the following optimal 
control problem (P) with inequality constraints and free terminal states defined over the prescribed 
interval 0, ft    [31]: 
 2 2 2 2 2 2 2 21 2 3 4 1 5 2 6 3 1 1 2 2
0
min
ft
J C E C H C P C I C I C I B u B u dt        , 
. .s t  
   1 4 1V u t S S d V      , 
  1 1 4 1S V u t d S          , 
  1 3 1 2 2 2 1 1pE S R H c u t d E             , 
 2 3 2 2 2 3H E P d H            , 
 3 4 1 4 3 3 3P H I d P            , 
 1 4 5 2 5 4 4 4 1I P I d I            ,                                            (10) 
 2 5 1 6 3 5 5 5 6 2I I I d I            , 
 3 6 2 6 6 6 7 3I I d I          , 
 7 3 7 1A I d d A      , 
   2 1 1 2 2 3 3 4 4 1 5 5 2 6 6 3 7 3 1pR c u t E H P I I I A d R                        , 
 0 sV V ,  0 sS S ,  0 sE E ,  0 sH H ,  0 sP P ,  1 10 sI I ,  2 20 sI I ,  3 30 sI I , 
 0 sA A ,  0 sR R , 
 1 1max0 u t u  ,  2 2 max0 u t u  , 
where ft R
  is the fixed terminal time, the coefficients 
1C , 2C , 3C , 4C , 5C , 6C , 1B  and 
2B  represent the corresponding weight constants, and these weights are balancing cost factors 
related to the size and importance of the parts of the objective function. The control function  1u t  
is the fraction of the population of susceptible individuals who enters the vaccination compartment. 
The control function  2u t  is the fraction of the population of infectious individuals with no 
symptoms who undergo HPV screening, and they are Lebesgue integrable. 
5.2. Characterization of optimal control 
The inequality constraints in problem (P) can be transformed into equality ones with the help of 
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some non-negative parametric parameters, that is,  1,2,3,4i i  , as 
1 1
1 1max 2
2 3
2 2 max 4
0,
0,
0,
0.
u
u u
u
u u




  
   

  
   
                             (11) 
Hence, the Hamiltonian function for problem (P) is obtained as follows: 
   
   
 
1 2
2 2 2 2 2 2 2 2
1 2 3 4 1 5 2 6 3 1 1 2 2
1 4 1 1 1 4 1
1 3 1 2 2 2 1 1 2 3 2 2 2 3
4 5 2 5 4 4 4 1 5 1 6 3
V S
E p H
I I
H C E C H C P C I C I C I B u B u
u S S d V V u d S
S R H c u d E E P d H
P I d I I I
      
              
          
        
                
               
            
   
 
       
3
5 5 5 6 2
6 2 6 6 6 7 3 7 3 7 1
2 1 1 2 2 3 3 4 4 1 5 5 2 6 6 3 7 3 1
1 1 1 2 1 1max 2 3 2 3 4 2 2 max 4 ,
I A
R p
d I
I d I I d d A
c u E H P I I I A d R
u u u u u u
  
        
               
       
    
              
          
           
     (12) 
where 
1 2 3
, , , , , , , , ,
T
V S E H P I I I A R               are adjoint variables, and  1 2 3 4, , ,
T
      
are non-negative penalty multipliers [32]. 
Theorem 5.1 There exists an optimal control     * *1 2,u t u t  and corresponding solution V , S , 
E , H , P , 1I , 2I , 3I , A , and R  that minimize     1 2,J u t u t  over  . Furthermore, 
there exist adjoint functions V , S , E , H , P , 1I , 2I , 3I , A  and R , such that 
1 1 3 1 31
1 1V S E V R
S R RS
a
N N N
    
     
 
       
 
, 
 1 1 3 1 311 4 1 1 1 4S S E R V
S R RS
d u u
N N N
    
        
  
             
   
, 
 11 3 3
1 2 3
1 3 1 3
2 1 1
2
       ,
E H E S
R p
S MS R MS MR
C E a
N N
R
c u
N
  
    
   
  
   
       
 
 
  
 
 
 1 11 3 1 1 3 1
2 3 2 4
1 3 3 1
2 2
2
        ,
H P E H S
R
S MMS MR R S
C H a
N N
R MR
N
      
      
   
  
   
        
 
 
  
 
 
 
1
2 3 2 1 3 1
3 4 3 5 2
2 1 1 3 3 2
3 3
2
       ,
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 
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1 3 1 3 1 1
7 9A R E A S
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 
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1 3 1 3 11
3 1 3 1R R S E
R R SS
d
N N N
    
       
   
         
   
,                                   (13) 
with transversality conditions 
        0V f S f A f R ft t t t       L .                (14) 
The following characterization holds 
 
 
 
 
*
1 1max
1
1 1*
2 2 max
2
max 0,min , ,
2
max 0,min , .
2
S V
p E R
S
u t u
B
Ec
u t u
B
 
   
    
   
    

     
   
    
               (15) 
Proof. The existence of an optimal control can be obtained owing to the convexity of the integrand 
of     1 2,J u t u t  with respect to     1 2,u t u t  [33], a priori boundedness of the state solutions, 
and the Lipschitz property of the state system with respect to the state variables. 
By Pontryagin’s maximum principle [34], the optimal conditions with respect to the state, 
costate, and parametric variables result in a two-point boundary value problem coupled with a 
nonlinear complementarity problem as follows: 
V
H
V
 
  

, 
S
H
S
 

  

, L , 
A
H
A
 

  

, 
R
H
R
 

  

,     (16) 
and 
        0V f S f A f R ft t t t       L , 
evaluated at the optimal control and corresponding states results in the stated adjoint system (13) 
with transversality (14). 
The optimality conditions with respect to the control variables are 
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1
0
H
u
 

, 
2
0
H
u
 

.                         (17) 
By solving Eq (17), the optimal control can be expressed as 
 
  1 2*
1
12
S VS
u t
B
     
 . 
To determine an explicit expression of the optimal control without 1 , we consider the 
following three cases: 
i. On the set  *1 1max0t u u  , we have 1 2 0   . Hence,  
 *
1
12
S VS
u t
B
 
 . 
ii. On the set  *1 1maxt u u , we have 2 0  . Hence,  
  1*
1 1max
12
S VS
u t u
B
   
  . As 
1 0  , it is determined that 
 
1max
12
S VS
u
B
 
 . 
iii. On the set  *1 0t u  , we have 1 0  . Hence,  
  2*
1
1
0
2
S VS
u t
B
   
  . As 2 0  , it is 
determined that 
 
1
0
2
S VS
B
 
 . 
Combining the above three cases, the optimal control 
*
1u  is characterized as 
 
 *
1 1max
1
max 0,min ,
2
S VS
u t u
B
    
   
   
.              (18) 
Using similar arguments, we can characterize the optimal control 
*
2u  as 
 
 1 1*
2 2 max
2
max 0,min ,
2
p E REc
u t u
B
       
   
    
.           (19) 
5.3. Numerical simulations 
An analytical expression of the optimal vaccination rate and screening rate was derived in Eq (15). 
However, an effective algorithm is still required to solve the nonlinear constrained optimal control 
problem numerically. Based on the generating function method, Peng et al. developed a series of 
symplectic methods for nonlinear optimal control problems [35−38]. Such symplectic methods have 
good precision and efficiency because of the structure-preserved property. Recently, Wang et al. 
improved the symplectic methods by incorporating the local pseudospectral discretization 
scheme [39−42]. Such symplectic pseudospectral methods (SPMs) have been successfully applied to 
solve optimal control problems in various mechanical systems [43−44]. In this paper, the SPM 
developed in [45] was adopted. 
In the following simulation, the weights in the objective function (meaning the minimization of 
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the number of patients at each stage has different importance) are 1 4.5 2C e  , 2 1 7C e  , 
3 1 4C e  , 4 1 5C e  , 5 2 4C e  , and 6 1 4C e  . Let 1M  . The initial values for the states 
and other parameters are listed in Table 4. Unless otherwise stated, the parameters used in each case 
were as listed in Table 3. 
Table 4. Parameter values used in Figure 7. 
Parameter Value Parameter Value 
sV  3.2607 6e  2sI  4.15 4e  
sS  3.2212 5e  3sI  1.68 4e  
sE  4.2204 4e  sA  1.29 3e  
sH  1.1162 7e  sR  6.3 3e  
sP  4 4e  ft  50  
1sI  1.15 5e  1maxu  1 
2 maxu  2    
 
 
 
 
Figure 7. Simulations of model (2). Dashed lines: Populations with optimal control. Solid 
lines: Populations without control. Parameter values are 1 8.3 8B e  and 2 4 8B e . 
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The controlled solutions together with the solutions for the uncontrolled case are presented in 
Figure 7. It can be seen that the control strategy is effective. Vaccinated individuals increase steadily 
and reach almost 400% at the terminal end. Susceptible individuals keep increasing and then stabilize 
during the whole period. The number of infected individuals decreases significantly when optimal 
control strategies are used compared to the number in the absence of control strategies. 
 
Figure 8. The different strategies of  1u t  and  2u t  are plotted for 1 4 9B e  and 
2 3 9B e . Other parameter values are the same as those in Figure 7. 
We considered another set of weights, the simulation results are shown in Figure 8. A higher 
focus on the control strategies leads to a drop in the importance of the vaccination and screening 
strategies. As the number of asymptomatic individuals depends on the immunity of the susceptible 
individuals and the protection of the susceptible population, we should consider strengthening their 
immunity or implement regular cost-effective screening to control HPV transmission. 
6. Conclusions 
The human papillomavirus is among the most common sexually transmitted infections. 
Following infection, cervical carcinogenesis is a complex stepwise process characterized by slow 
progression. According to the known pathology, we represented the CIN stages with three 
corresponding components in the model. Our model accounted for the fact that preventive vaccines 
become ineffective over time. We derived three types of equilibria and their conditions of existence, 
analyzed the stability of the equilibria, and characterized the threshold condition as backward 
bifurcation for the stable fixed points. We also obtained the conditions for the elimination of the 
disease. We found that the possibility of HPV transmission to lead to endemic disease can be reduced 
by strengthening the protection after cure. We then simulated and compared practical mitigation 
strategies and performed sensitivity analysis to illustrate the key factors for the threshold condition. 
The results show that increasing the vaccination rate is the most effective way to reduce the basic 
reproduction number. The effect of optimal control was illustrated numerically, and a comparison of 
HPV infection was presented under different control strategies. 
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Appendix A 
Table A1. A detailed explanation of Theorem 3.2. 
a  c  b  Results 
0a   
0c   
0b   Two negative points 
0b   No equilibrium points 
0b   Two endemic equilibria if 2 4 0b ac   
0c   
0b   A negative point and a DFE 
0b   Two DFE 
0b   A DFE and an EEP (or 
2 4 0b ac  ) 
0c   
0b   A negative point and an EEP 
0b   A negative point and an EEP 
0b   A negative point and an EEP 
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Appendix B 
Here, we explore the existence of backward bifurcation using the center manifold theory [46−47]. 
To apply this theory, it is necessary to carry out the following change of variables. 
Let 1E x , 2H x , 3P x , 3 4I x , 2 5I x , 1 6I x , 7A x , 8R x , 9S x , 
10V x , so that 
10
1
i
i
N x

 . 
Further, using the vector notation 
 1 1 2 3 4 5 6 7 8 9 10, , , , , , , , ,
T
X x x x x x x x x x x . 
Model (2) can be rewritten in the form 
 1 1 2 3 4 5 6 7 8 9 10, , , ,
TdX
F f f f f f f f f f f
dt
  ， ， ， ， ， , 
as follows: 
             
       
       
     
     
   
1
1 9 3 1 7 2 3 2 1 1 1
2
2 1 3 3 2 2 2 3 2
3
3 2 4 6 4 3 3 3 3
4
6 5 6 6 6 7 4
5
5 6 6 4 5 5 5 6 5
6
4 3 5 5 5 4 4
,
,
,
,
,
p q
dx
t x t t x t x t c c d x t
dt
dx
x t x t d x t
dt
dx
x t x t d x t
dt
dx
x t d x t
dt
dx
x x t d x t
dt
dx
x t x t
dt
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     
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    
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4 6
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p q
d x t
dx
x t d d x t
dt
dx
c c x t x t x t x t x t x t x t
dt
t d x t
dx
x t t d x t
dt
dx
x t x t d x t
dt

 
            
 
   
  















 


    


       

  


      
   




   (B.1) 
with 
 
  1 1 2 2 3 3 6 4 5 5 4
1
1
n k c a
c c c c x x x x x x
t
N
     

     
 . 
Consider the case when 
0
=1R . Suppose, further, that 
2
  is chosen as a bifurcation parameter. 
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Solving for 
2 2
 
*
 from 
0
R  gives 
 
1 1
2 1 4
3 6 2 5
a MM
a
a D D
 

  

*
. 
The Jacobian of model (B.1) evaluated at the DFE is given as 
  11 120
21 22
J J
J
J J

 
  
 
, 
where 
10 3 10 1 2 10 2 10 5 10 4 10 3
2 4 3
3 5 4
11
8 6
6 7 5
4 5 6
0 0 0
0 0 0
0 0 0 0
0 0 0
0 0 0
a a a a a a a
a
a
J
a
a
a
     
 
 

 
 
  
 
 
 
  
 
 
 
  
,  12 6 40J  , 
7
1 1 2 2 3 3 6 6 5 5 4 4
21
10 10 1 10 4 10 3 10 2
0 0 0 0 0
0
0 0 0 0 0 0
p qc c
J
a a a a a

           
   
 
 
 
     
 
 
, 
9
7
22
2 1
2 4 1
0 0 0
0 0
0 0
0 0
a
d
J
a
a


 
 
 
 
 
 
  
. 
It is easy to verify that the transformed model (B.1), with 
2 2
 
*
, has a hyperbolic 
equilibrium point (i.e., the linearized system has a simple eigenvalue with zero real part, and all other 
eigenvalues have negative real parts). Hence, the center manifold theory can be used to analyse the 
dynamics of model (B.1) near 
2 2
 
*
. 
It can be shown that the Jacobian of model (B.1) at 
2 2
 
*
 has a right eigenvector 
(associated with the zero eigenvalue) given by  1 2 3 4 5 6 7 8 9 10, , , , , , , , ,
T
w w w w w w w w w w w , where 
4 5 3 4
1 4 6 4
2
0
a D D
w w D w



   , 5 4 4 32 4 5 4
3
0
a D D
w w D w



   , 
6 3 5 2
3 4 4 4
4
0
a D D
w w D w



   , 4 4 0w w  , 
8
5 4 2 4
6
0
a
w w D w

   , 
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7 2 6
6 4 3 4
5
0
a D
w w D w



   , 77 4 1 4
9
0w w D w
a

   , 
1 1 6 2 2 5 3 3 4 6 6 5 5 2 4 4 3 7 1
8 4 0
p qc c D D D D D D
w w
d
                 
  , 
1
9 10 1 2 4 3 4
2 4
a
w w G G w G w
 
  

, 
2 5 3 6
10 4 2 4
2 1 1
D a D
w w G w
a G



 

. 
The components of the left eigenvector of 
0
2 2
J

  *
,  1 2 3 4 5 6 7 8 9 10, , , , , , , , ,v v v v v v v v v v v , satisfying 
1v w   are 
1 0v  , 
3
2 1
2
a
v v

 , 3 4 2 23 1
2 3
0
a a
v v
 
 

  , 64 5
8
v v
a

 , 
3 4 5 6 5 6 2 2 3 6 3 3 3 4 4 4 4 4 2 2
5
2 3 4 5
0
a a a a a a a a a a
v
         
   
   
  , 
3 4 5 5 2 2 3 3 3
6
2 3 4
0
a a a a a
v
   
  
 
  , 7 8 0v v  , 9 1v v , 
1
10 1
1
v v
a

 . 
It follows from [26]: 
 
210
, , 1
0,0kk i j
k i j i j
f
a v
x x




 
 ,  
210
, 1 2*
0,0kk i
k i i
f
b v
x




 
 , 
are computed to be 
 
 
210
, , 1
1 8 3
1 1 2 2 3 5 4 3 60 0
0,0
2
0,
k
k i j
k i j i j
f
a v w w
x x
v w M
w w w w w
S V

   



 
    



           (B.2) 
 
   
210
, 1 2*
2 2
9 10
9 9 10 9
9 2* 9 2*
2 5 3 6 2 5 3 61 1 1
1 4 1 4
2 1 1 2 4 1 2 1 1 2 4
2 5 3 61 1
1 4
1 2 41
2 1
2 4
0,0
0,0 0,0
1
0.
k
k i
k i i
f
b v w
x
f f
v w v w
x x
D a D D a Da a
v w v w
a G a a G
D a D a
v w
a a
a

 
 
     

 

 



 
 
 
   
 
    
   
  
   
    
 


 (B.3) 
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Thus, we have made the following conclusions 
Theorem A.1 Model (B.1) (or, equivalently, model (2)) undergoes a backward bifurcation at 
0
1R   
if all parameters are positive. 
Appendix C 
Table C1. PRCC values of 0R  with corresponding values of p  (significant for p ≤ 0.01). 
Parameter PRCC values 
1  0.1079 1.3332e-06 
2  0.0619 0.0056 
3  0.0375 0.0939 
4  0.0363 0.1050 
5  0.0130 0.5625 
1  0.2219 1.0079e-23 
2  −0.0972 1.3420e-05 
3  0.0139 0.5334 
4  −0.0503 0.0246 
1  −0.0474 0.0342 
2  −0.0907 4.8958e-05 
3  −0.1749 3.3636e-15 
4  −0.0631 0.0047 
5  −0.0038 0.8662 
6  0.0162 0.4703 
1  −0.0491 0.0280 
2  −0.1101 7.9369e-07 
3  −0.1100 8.1799e-07 
4  −0.0857 0.0001 
5  −0.0117 0.6015 
6  −0.0179 0.4227 
7  −0.0254 0.2562 
2  0.1070 1.6317e-06 
3  0.0391 0.0806 
4  0.0389 0.0823 
5  0.0347 0.1209 
6  −0.0100 0.6578 
Continued on next page 
p
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Parameter PRCC values 
7  −0.0331 0.1389 
  0.0106 0.6363 
1d  0.0018 0.9352 
d  −0.2728 1.7789e-35 
pc  −0.1683 3.5473e-14 
qc  −0.1044 2.9039e-06 
cc  −0.0685 0.0022 
ac  −0.0648 0.0037 
nc  0.3778 7.0664e-69 
kc  0.2383 3.1497e-27 
  0.2481 1.9591e-29 
  0.6344 1.0688e-225 
 
©2020 the Author(s), licensee AIMS Press. This is an open access 
article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/4.0) 
p
